Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Ippolito JE, et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Natl. Acad. Sci. 102(28):9901-9906, 2005. PubMed: 15998737
Hu Y, et al. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites. Proc. Natl. Acad. Sci. 101(15):5559-5564, 2004. PubMed: 15060276 GeneChip analyses of cell lines harvested at different passages, and as xenografted tumors, indicated that PNECs express consistent features ex vivo and in vivo and share a remarkable degree of similarity with primary CR2-TAg prostate neuroendocrine (NE) tumors.
PNECs express mAsh1 (mouse homolog proneural gene complex achaete-scute), a basic helix-loop-helix (bHLH) transcription factor essential for NE cell differentiation in other tissues. PNEC cell lines should be useful for genetic and/or pharmacologic studies of the regulation of NE cell proliferation, differentiation, and tumorigenesis.
Volumes used in this protocol are for 75 cm2. flasks; proportionally reduce or increase amount of solutions for culture vessels of other sizes.
Ippolito JE, et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Natl. Acad. Sci. 102(28):9901-9906, 2005. PubMed: 15998737
Hu Y, et al. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites. Proc. Natl. Acad. Sci. 101(15):5559-5564, 2004. PubMed: 15060276
Hu Y, et al. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites. Proc. Natl. Acad. Sci. 101(15):5559-5564, 2004. PubMed: 15060276
